You have 9 free searches left this month | for more free features.

08-123

Showing 1 - 25 of 2,874

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acne Vulgaris Trial in Canada, United States (IDP-123 Lotion, IDP-123 Vehicle Lotion)

Completed
  • Acne Vulgaris
  • IDP-123 Lotion
  • IDP-123 Vehicle Lotion
  • Phoenix, Arizona
  • +44 more
Mar 30, 2021

Acne Vulgaris Trial in Canada, United States (IDP-123 Lotion, IDP-123 Vehicle Lotion)

Completed
  • Acne Vulgaris
  • IDP-123 Lotion
  • IDP-123 Vehicle Lotion
  • Mobile, Alabama
  • +44 more
Mar 30, 2021

Acne Vulgaris Trial in United States (IDP-123 Lotion, Tazorac Cream, Vehicle Lotion)

Completed
  • Acne Vulgaris
  • IDP-123 Lotion
  • +3 more
  • Encinitas, California
  • +15 more
Sep 3, 2020

Healthy Adults Trial (Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L, DREP-HIV-PT1 1mg and CN54gp140/MPLA-L (see above), DNA-HIV-PT123

Not yet recruiting
  • Healthy Adults
  • Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L
  • +2 more
  • (no location specified)
Apr 9, 2021

IgA Nephropathy, Berger Disease Trial in Worldwide (Atacicept, Placebo to match Atacicept)

Active, not recruiting
  • IgA Nephropathy
  • Berger Disease
  • Atacicept
  • Placebo to match Atacicept
  • Tucson, Arizona
  • +75 more
Jul 6, 2022

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
  • Birmingham, Alabama
  • +91 more
Jan 26, 2023

Patients Who Receive Colonoscopy Trial in Japan (NPF-08 (1-day treatment), NPF-08 (2-day split dose), Moviprep(1-day treatment))

Completed
  • Patients Who Receive Colonoscopy
  • NPF-08 (1-day treatment)
  • +2 more
  • Abiko, Chiba, Japan
  • +12 more
Nov 27, 2022

Systemic Lupus Erythematosus (SLE) Trial (Descartes-08)

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • (no location specified)
Sep 8, 2023

Differentiated Thyroid Cancer Trial (Low iodine diet)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Low iodine diet
  • (no location specified)
Oct 25, 2022

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Parkinson Disease Trial in Paris (Identification of COMT HH, COMT HL or COMT LL genes, Brain MRI with resting state scan, Brain

Completed
  • Parkinson Disease
  • Identification of COMT HH, COMT HL or COMT LL genes
  • +2 more
  • Paris, France
    Groupe Hospitalier Pitié-Salpêtrière
Feb 17, 2022

Myasthenia Gravis, Generalized Trial in United States (Descartes-08)

Recruiting
  • Myasthenia Gravis, Generalized
  • Carlsbad, California
  • +8 more
Jan 27, 2023

Solid Tumor, Adult Trial in Shanghai (3D011-08)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Floor 2, Building 2, 270 Dong 'an Road, Xuhui District, China
    Fudan University Shanghai Cancer Center
Jan 2, 2023

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +6 more
  • Iowa City, Iowa
  • +60 more
Jan 3, 2023

Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Recruiting
  • Acute Myeloid Leukemia
  • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Malignancy of Thyroid Nodules Trial in France (MIBI-Tc99m/Iodine-123)

Unknown status
  • Malignancy of Thyroid Nodules
  • Angers, France
  • +6 more
Feb 8, 2021

MDD (MDD) Trial (Aripiprazole, Escitalopram)

Terminated
  • Major Depressive Disorder (MDD)
  • (no location specified)
Nov 24, 2021

Epilepsies, Partial Trial in United States (ganaxolone)

Completed
  • Epilepsies, Partial
  • Birmingham, Alabama
  • +24 more
Dec 20, 2022

Bacterial Ecology of Pilonidal Cysts

Recruiting
  • Pilonidal Cysts
    • Lyon, France
      Clinique de la Sauvegarde
    Aug 23, 2022

    Chemo-induced Peripheral Neuropathy Trial in Japan, United States (thrombomodulin alfa, Placebo)

    Recruiting
    • Chemotherapy-induced Peripheral Neuropathy
    • thrombomodulin alfa
    • Placebo
    • Beverly Hills, California
    • +14 more
    May 26, 2022

    Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

    Recruiting
    • Platinum-refractory Ovarian Carcinoma
    • Platinum-resistant Ovarian Cancer
    • TILT-123
    • Pembrolizumab
    • Rochester, Minnesota
    • +1 more
    Aug 12, 2022

    Pulmonary Arterial Hypertension Trial (MN-08 24 mg/day, MN-08 60 mg/day)

    Not yet recruiting
    • Pulmonary Arterial Hypertension
    • MN-08 24 mg/day
    • MN-08 60 mg/day
    • (no location specified)
    Dec 14, 2022